Suppr超能文献

[奇溴替莫托在眼科实践中使用一年后的应用报告(作者译)]

[Report on the application of chibro-timoptol after one year's use in ophthalmological practice (author's transl)].

作者信息

Täumer R, Gross G

出版信息

Klin Monbl Augenheilkd. 1980 Sep;177(3):384-9. doi: 10.1055/s-2008-1057660.

Abstract

A summary is given of the common methods of treating glaucoma medically, beginning with the introduction of pilocarpine over 100 years ago and ending, for the time being, with the application of the beta-blocker Timolol Maleat (Chibro-Timoptol). The authors have been using Chibro-Timoptol for over a year and have treated more than 300 patients by this method so far. Timolol proved to have significant advantages over all other pressure-lowering drugs used in the past. It was just as effective or more effective than the substances used previously. For a newly diagnosed glaucoma, the authors therefore recommend using Timolol in all initial attempts at pressure regulation.

摘要

本文总结了青光眼的常见药物治疗方法,始于100多年前毛果芸香碱的引入,目前以β受体阻滞剂马来酸噻吗洛尔(奇罗-噻吗心安)的应用为终点。作者使用奇罗-噻吗心安已逾一年,迄今为止已用此方法治疗了300多名患者。事实证明,噻吗洛尔比过去使用的所有其他降压药物都具有显著优势。它与先前使用的药物效果相当或更有效。因此,对于新诊断的青光眼,作者建议在所有初始眼压调节尝试中使用噻吗洛尔。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验